BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6135721)

  • 1. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam.
    Smith RB; Divoll M; Gillespie WR; Greenblatt DJ
    J Clin Psychopharmacol; 1983 Jun; 3(3):172-6. PubMed ID: 6135721
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties of benzodiazepine hypnotics.
    Greenblatt DJ; Abernethy DR; Divoll M; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):129-32. PubMed ID: 6132931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temazepam clearance unaltered in cirrhosis.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
    Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of benzodiazepine hypnotics.
    Greenblatt DJ; Divoll M; Abernethy DR; Locniskar A; Shader RI
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():70-5. PubMed ID: 6145683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlormethiazole and temazepam.
    Br Med J (Clin Res Ed); 1981 Mar; 282(6266):825. PubMed ID: 6111373
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of benzodiazepine hypnotics.
    Greenblatt DJ; Divoll M; Abernethy DR; Locniskar A; Shader RI
    Pharmacology; 1983; 27 Suppl 2():70-5. PubMed ID: 6142469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the hypnotic benzodiazepine, temazepam.
    Bittencourt P; Richens A; Toseland PA; Wicks JF; Latham AN
    Br J Clin Pharmacol; 1979; 8(1):37S-38S. PubMed ID: 41541
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of age and gender on disposition of temazepam.
    Divoll M; Greenblatt DJ; Harmatz JS; Shader RI
    J Pharm Sci; 1981 Oct; 70(10):1104-7. PubMed ID: 6117653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative pharmacokinetics of 5 hypnotic benzodiazepines in healthy volunteers].
    Jochemsen R; Van Boxtel CJ; Breimer DD
    Nouv Presse Med; 1982 Oct; 11(40):2965-6. PubMed ID: 6128720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of the newer benzodiazepines.
    Greenblatt DJ; Divoll M; Abernethy DR; Ochs HR; Shader RI
    Clin Pharmacokinet; 1983; 8(3):233-52. PubMed ID: 6133664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temazepam in geriatric patients.
    Klem K; Murray GR; Laake K
    Eur J Clin Pharmacol; 1986; 30(6):745-7. PubMed ID: 2876901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Moschitto LJ; Smith RB; Shader RI
    Br J Clin Pharmacol; 1983 Mar; 15(3):303-9. PubMed ID: 6133545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam.
    Greenblatt DJ; Harmatz JS; Engelhardt N; Shader RI
    Arch Gen Psychiatry; 1989 Apr; 46(4):326-32. PubMed ID: 2564763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypnotics and anxiolytics.
    Br Med J (Clin Res Ed); 1983 Jul; 287(6387):289-90. PubMed ID: 6135488
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of age and chronic liver disease on the elimination of temazepam.
    Ghabrial H; Desmond PV; Watson KJ; Gijsbers AJ; Harman PJ; Breen KJ; Mashford ML
    Eur J Clin Pharmacol; 1986; 30(1):93-7. PubMed ID: 2872062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Smith RB; Shader RI
    Clin Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6143633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) people.
    O'Connor-Semmes RL; Kersey K; Williams DH; Lam R; Koch KM
    Clin Pharmacol Ther; 2001 Aug; 70(2):126-31. PubMed ID: 11503006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazolam and ethanol interaction: kinetic and dynamic consequences.
    Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D
    Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.